Status:
ENROLLING_BY_INVITATION
The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer
Lead Sponsor:
Başakşehir Çam & Sakura City Hospital
Conditions:
Colorectal Cancer
Colorectal Adenocarcinoma
Eligibility:
All Genders
Brief Summary
As a hypothesis and shown in many meta-analyses and randomized controlled studies, minimally invasive surgery causes less surgical trauma and therefore less proinflammatory response and immunosuppress...
Detailed Description
Minimally invasive surgery has been demonstrated to significantly enhance the host immune response in colorectal cancer. The effect and the SII marker may be reliable indicators of this enhancement. A...
Eligibility Criteria
Inclusion
- Patients operated for rectal cancer
- Open surgery
- Laparoscopic surgery
- Robotic surgery
Exclusion
- Patients with diagnosed immune deficiency
- Patients with recurrent colorectal cancer
- Patients with co-existent tumors
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06540027
Start Date
June 1 2024
End Date
March 1 2025
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yigit Duzkoylu
Istanbul, Turkey (Türkiye), 34480